The Hair Loss Timeline: When It Starts, Peaks, and Stops Source: Dermatology literature on telogen effluvium + GLP-1 clinical trial adverse event data (STEP and SURMOUNT trials)
GLP-1 Binding The EM structure of the GLP-1 apo receptor (i.e., receptor in the absence of any ligand), shows that the N-terminal domain adopts a closed or inactive conformation, where a cap-like structure blocks access to the peptide binding ( PDB ID 6ln2, Wu et al., 2020, Figure 4a)
Trials show roughly 25-40% of weight lost on a GLP-1 can be muscle, and enough protein plus simple strength work keeps most of that muscle
Patients can easily schedule appointments at their Brooklyn location
doi: 10.3389/fmicb.2023.1272754 522 SwansonKSGibsonGRHutkinsRReimerRAReidGVerbekeKet al